INDIRA TRADE : Gateway to Prosperity

IPO

IPO Snapshot

Onyx Biotec Ltd.

Issue Open Date	13-Nov-24
Issue Closing Date	18-Nov-24
Application Money	100
Allotment Money

Price Band ()	58 - 61
Minimum Bid Quantity.	2000
Issue Size (Shares)	3444000
Market Lot	1

Objective

1. Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use.2. Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections.3. Prepayment or repayment of all or a portion of certain loans availed by our Company.4. General Corporate Purposes.

Business Description

Onyx started its operation in pharmaceutical industry with sterile water for injections in the year 2010. Since then,Onyx has been associated with the healthcare segment and offering Sterile Pharmaceutical products and has becomea prominent supplier of sterile products to major corporations, which includes the top pharma companies at pan Indialevel. Onyx is committed to provide high-quality pro...

Promoter's Holding

Total Share Capital	11803200
Offered to Public	4810000
Promoter's Holding (Pre-Issue)	88.6
Promoter's Holding (Post-Issue)	65.1

Address

Address :Bir Plassi Near Sainimajraropar
Nalagarh Road
City :Solan Dist, State :Himachal Pradesh Pincode :174101 Phone : Email : generalinfo@onyxbiotec.com Website : www.onyxbiotec.com

Registrar

MAS Services Ltd
T-34
2nd Floor
Okhla Industrial Area
Phase - II
New Delhi

Listed at

NSE

Lead Manager

Horizon Management Pvt Ltd.

Promoters

Fateh Pal Singh
Harsh Mahajan
Lakshya Jain
Naresh Kumar
Parmjeet Kaur
Sanjay Jain

ATTENTION INVESTORS
KYC
CDSL

Prevent Unauthorized Transactions in your demat and trading account --> Update your Mobile Number/Email id with your Depository Participant and Stock Broker. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat/trading account directly from CDSL and Stock Exchanges on the same day.........issued in the interest of investors...

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your Mobile Number & Email Id with your Stock Broker/ Depository Participant and receive OTP directly from Depository on your Email Id and/ or Mobile Number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued by NSE vide. Circular No. NSE/INSP/45191 dated: July 31, 2020 and NSE/INSP/45534 and BSE vide Notice No. 20200731-7, dated: July 31, 2020 and 20200831- 45 dated: August 31, 2020 and dated: August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities/ MF/ Bonds in the Consolidated Account Statement issued by NSDL/ CDSL every month.

6. Risk disclosures RISK DISCLOSURES ON DERIVATIVES:

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html
We believe that an educated investor is a protected investor !!!

"As per the directives of CDSL and esteemed Exchanges, it has been made mandatory for every client to furnish their latest KYC details viz. Valid Mobile No., Email- Id & Income range on or before 31.05.2021 else your Account will be marked as Non Compliant and will be Freezed till the compliance of such requirement."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

Dear Investor if you wish to revoke your un-executed eDis mandate, please mail us with ISIN and quantity on dp@indiratrade.com by today EOD."

REGISTRATION NOS:

INDIRA SECURITIES PRIVATE LIMITED (SEBI REG.NO.):NSE TMID: 12866, BSE TMID: 663, CDSL DPID: 17000 SEBI REG. NO.: INZ000188930, MCX TM ID: 56470, NCDEX TM ID: 01277, CDSL REG. NO.: IN-DP-90-2015, CIN : U67120MH1996PTC160201

DISCLAIMER:

"INVESTMENT IN SECURITIES MARKET ARE SUBJECT TO MARKET RISKS, READ ALL THE RELATED DOCUMENTS CAREFULLY BEFORE INVESTING."

INVESTORS GRIEVANCE

Indrendu Joshi. Email: compliance@indiratrade.com. Call : 0731-4797275

Investor grievance complaint : complaint@indiratrade.com

INVESTOR CHARTER